With the analysis among 830 patents, we discovered top 171 key players by total patent application. ImClone LLC, Novartis AG, Bristol Myers Squibb Co. are dominant in this area. They take 16.87% of the total patent filing.
New York, United States
Patent: 58
Basel-Stadt, Switzerland
Patent: 48
New York, United States
Patent: 34
California, United States
Patent: 34
California, United States
Patent: 21
Kanagawa-ken, Japan
Patent: 19
Indiana, United States
Patent: 17
Colorado, United States
Patent: 17
California, United States
Patent: 16
With the analysis among 21 patents, we discovered top 7 start-ups by total patent application. Akouos, Inc., Immunowake, Cloudbreak Therapeutics LLC are active in this area.
Massachusetts, United States
Patent: 10
Alabama, United States
Patent: 4
California, United States
Patent: 2
Guangdong Sheng, China
Patent: 2
Shanghai Shi, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Guangdong Sheng, China
Patent: 1
With the analysis among related 197 patents applied in the last 5 years. We discover 90 most active companies in this area. The fast-growing Akouos, Inc., Shimojani LLC, Beijing InnoCare Pharma Tech Co., Ltd. take 13.20% of patent filing during this period.
Massachusetts, United States
Patent: 10
California, United States
Patent: 8
Beijing Shi, China
Patent: 8
New York, United States
Patent: 5
Alabama, United States
Patent: 4
With the analysis among related 197 patents in last 5 years, we discover 66 new entrants. Akouos, Inc., Beijing InnoCare Pharma Tech Co., Ltd., ADS Therapeutics LLC are the most active new entrants in this area.
Massachusetts, United States
Patent: 10
Beijing Shi, China
Patent: 8
Alabama, United States
Patent: 4
Noord-Brabant, Netherlands
Patent: 3
Guangdong Sheng, China
Patent: 3
With the analysis among 245 patents, we discovered top 52 universities and scientific research institutions by total patent application. Vlaams Instituut voor Biotechnologie - Flanders Institute, China Pharmaceutical University, University of Tokyo are dominant in this area. They take 20.00% of the total patent filing.
Jiangsu Sheng, China
Patent: 14
Tokyo-to, Japan
Patent: 10
Pennsylvania, United States
Patent: 10
California, United States
Patent: 5
Massachusetts, United States
Patent: 5
Sichuan Sheng, China
Patent: 4